Doriano Fabbro

Chief Scientific Officer at PIQUR Therapeutics AG

Doriano Fabbro

Doriano Fabbro

Chief Scientific Officer at PIQUR Therapeutics AG

Biography

Dr. Doriano Fabbro, Chief Scientific Officer, received his Ph.D. in cell biology and biochemistry at the University of Basel, where he worked afterwards for 12 years as Group Leader in Molecular Tumor Biology. In 1991, he joined the Oncology Group of Ciba-Geigy Basel. After the merger of Ciba-Geigy with Sandoz in 1996 he served at Novartis as Head of Kinase Biology until 2012.

Doriano has contributed to the discovery and development of various protein kinase inhibitors for the treatment of cancer; e.g. Midostaurin®, Glivec®, Afinitor®, and Tasigna®. Doriano is author in more than 200 publications and numerous patents in the area of protein kinases regulation, structure, screening and drug discovery. He has been honored with the Novartis Oncology President's Award (2005).

Overview
RelSci Relationships

398

Number of Boards

1

Relationships
RelSci Relationships are individuals Doriano Fabbro likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Inventages Venture Capital Investment, Inc.

Relationship likelihood: Strong

Advisor at Blueprint Medicines Corp.

Relationship likelihood: Strong

Head of Quality Assurance at PIQUR Therapeutics AG

Relationship likelihood: Strong

Chief Executive Officer at PIQUR Therapeutics AG

Relationship likelihood: Strong

Chairman at PIQUR Therapeutics AG

Relationship likelihood: Strong

Chief Financial Officer at PIQUR Therapeutics AG

Relationship likelihood: Strong

President & Chief Executive Officer at SignalChem Lifesciences Corp

Relationship likelihood: Average

Director at Synosia Therapeutics AG

Relationship likelihood: Average

Head Drug Discovery at PIQUR Therapeutics AG

Relationship likelihood: Average

President, Xellia US at Xellia Pharmaceuticals

Relationship likelihood: Weak

Paths to Doriano Fabbro
Potential Connections via
Relationship Science
You
Doriano Fabbro
Chief Scientific Officer at PIQUR Therapeutics AG
Education
Ph.D Cell Biology & Biochemistry
Career History
Chief Scientific Officer
Current

PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland.

Head of Kinase Biology
Prior

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Boards & Committees
Member, Scientific Advisory Board
2014 - Current
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10 - $99
2015
Other Affiliations

Doriano Fabbro is affiliated with PIQUR Therapeutics AG, Novartis AG, SignalChem Lifesciences Corp

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Doriano Fabbro. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Doriano Fabbro's profile does not indicate a business or promotional relationship of any kind between RelSci and Doriano Fabbro.